Our Solution
AlphaLiquid® Platform
Publication
AlphaLiquid®
AlphaLiquid® Profiling
CancerDetect™
CancerFind™
Service
Clinical Service
BioPharma
Research
Healthcare Checkup
Company
IMBdx
Leadership
News
Media Library
Events
Contact Us
KR
JP
menu
Our Solution
Our Solution
AlphaLiquid® Platform
Publication
AlphaLiquid®
AlphaLiquid®
AlphaLiquid® Profiling
CancerDetect™
CancerFind™
Service
Service
Clinical Service
BioPharma
Research
Healthcare Checkup
Company
Company
IMBdx
Leadership
News
News
Media Library
Events
Innovative liquid biopsy platform
with industry-leading performance
Revolutionary genomic & epigenomic
analyses for the early detection of cancer
Precision oncology solutions
throughout the full continuum of
cancer care
AlphaLiquid®
Read More
Liquid Biopsy-Based Ultra-sensitive Cancer Diagnostic Technology
Cutting-Edge Liquid Biopsy Technology
Industry leading test performance based on proprietary bioinformatics
Robustly validated through clinical studies
Product
AlphaLiquid®100/HRR
Genomic profiling & monitoring
for advanced cancer patient
Read More
CancerDetect™
Recurrence monitoring &
Minimal Residual Disease (MRD) detection
for post-operative patients
Read More
CancerFind™
Blood-Based Multi-Cancer
Early Detection
Read More
Our Service
Clinical Practice
Monitor in real-time
for a better
treatment strategy
Read More
BioPharma
Enhance safety,
speed and efficiency in
clinical trials
Read More
Research
Accelerate and enrich
translational research
Read More
HealthCare Checkup
Genotyping of
cancer-related genes for
multiple types of tumors
through a simple blood test
Read More
News
Read More
IMBdx, AstraZeneca Expand …
2023.06.08
IMBDx Attends 'KoreaB…
2021.02.10
IMBdx at the BIO Internati…
2024.06.03